|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3-4
|
|
pubmed:dateCreated |
1985-3-27
|
|
pubmed:abstractText |
The therapeutic effect and safety of alprazolam and doxepin were studied in 126 outpatients suffering from primary unipolar depression. The 6-week study was double-blind with a random allocation of treatment. Patients were treated with a flexible dose of 1.0-4.5 mg of alprazolam and 50-225 mg of doxepin per day. The mean final doses were 2.7 mg for alprazolam and 137.5 mg for doxepin. The results indicate that alprazolam and doxepin were equally efficacious. The incidence of side-effects was lower in the alprazolam treatment group.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0165-0327
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
287-96
|
|
pubmed:dateRevised |
2009-9-28
|
|
pubmed:meshHeading |
pubmed-meshheading:6151958-Adolescent,
pubmed-meshheading:6151958-Adult,
pubmed-meshheading:6151958-Aged,
pubmed-meshheading:6151958-Alprazolam,
pubmed-meshheading:6151958-Anti-Anxiety Agents,
pubmed-meshheading:6151958-Benzodiazepines,
pubmed-meshheading:6151958-Clinical Trials as Topic,
pubmed-meshheading:6151958-Depressive Disorder,
pubmed-meshheading:6151958-Dose-Response Relationship, Drug,
pubmed-meshheading:6151958-Double-Blind Method,
pubmed-meshheading:6151958-Doxepin,
pubmed-meshheading:6151958-Female,
pubmed-meshheading:6151958-Humans,
pubmed-meshheading:6151958-Male,
pubmed-meshheading:6151958-Middle Aged,
pubmed-meshheading:6151958-Psychological Tests
|
|
pubmed:year |
1984
|
|
pubmed:articleTitle |
Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
